Journey Medical Corporation DERM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$11.43M— | —— | -$3.85M+87.0% | -$29.63M+32.7% | ||
| $6.29M+3.1% | $6.1M+134% | $2.61M-41.1% | $4.43M+79.4% | ||
| -$12.44M— | —— | —— | -$13.53M-521% | ||
| —— | —— | —— | —— | ||
| $16.23M-6.1% | $17.29M— | —— | $16.46M-69.0% | ||
| —— | -$7.13M— | —— | -$17.08M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Journey Medical Corporation generate?
- Journey Medical Corporation (DERM) generated -$6.7M in operating cash flow over the trailing twelve months.
- Where does Journey Medical Corporation's cash flow data come from?
- Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
